PRODUCT DETAIL

Kandoset 8 mg/5 mg tablety

Code

7829C

MA number

58/0150/18-S

Product Form:

tbl 10x8 mg/5 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DB	Angiotensin II antagonists and calcium channel blockers
C09DB07	Candesartan and amlodipine

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	14.05.2018
Pediatric contraindication:	Yes
Pediatric warnings:	Yes
PIL:	PIL_Kandoset_01/2023.pdf
SPC:	SPC_Kandoset_01/2023.pdf
Safety feature	Yes
Data update:	30.05.2023